Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 2
1984 1
1985 1
1986 4
1988 2
1990 1
1994 2
1995 1
1996 1
1998 4
1999 4
2000 9
2001 6
2002 13
2003 6
2004 6
2005 4
2006 15
2007 6
2008 8
2009 5
2010 7
2011 5
2012 8
2013 13
2014 14
2015 11
2016 9
2017 3
2018 7
2019 7
2020 13
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 10920169

186 results
Results by year
Filters applied: . Clear all
Page 1
Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
Advisory Committee on Immunization Practices. Advisory Committee on Immunization Practices. MMWR Recomm Rep. 2000 Oct 6;49(RR-9):1-35. MMWR Recomm Rep. 2000. PMID: 11055835 Free article.
Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP).
Nuorti JP, Whitney CG; Centers for Disease Control and Prevention (CDC). Nuorti JP, et al. MMWR Recomm Rep. 2010 Dec 10;59(RR-11):1-18. MMWR Recomm Rep. 2010. PMID: 21150868 Free article.
No long-term evidence of hyporesponsiveness after use of pneumococcal conjugate vaccine in children previously immunized with pneumococcal polysaccharide vaccine.
Licciardi PV, Toh ZQ, Clutterbuck EA, Balloch A, Marimla RA, Tikkanen L, Lamb KE, Bright KJ, Rabuatoka U, Tikoduadua L, Boelsen LK, Dunne EM, Satzke C, Cheung YB, Pollard AJ, Russell FM, Mulholland EK. Licciardi PV, et al. J Allergy Clin Immunol. 2016 Jun;137(6):1772-1779.e11. doi: 10.1016/j.jaci.2015.12.1303. Epub 2016 Jan 26. J Allergy Clin Immunol. 2016. PMID: 26825000 Free PMC article. Clinical Trial.
Updated recommendation from the Advisory Committee on Immunization Practices (ACIP) for use of 7-valent pneumococcal conjugate vaccine (PCV7) in children aged 24-59 months who are not completely vaccinated.
Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention (CDC), et al. MMWR Morb Mortal Wkly Rep. 2008 Apr 4;57(13):343-4. MMWR Morb Mortal Wkly Rep. 2008. PMID: 18385642 Free article.
Safety and immunogenicity of the American Academy of Pediatrics--recommended sequential pneumococcal conjugate and polysaccharide vaccine schedule in pediatric solid organ transplant recipients.
Lin PL, Michaels MG, Green M, Mazariegos GV, Webber SA, Lawrence KS, Iurlano K, Greenberg DP. Lin PL, et al. Pediatrics. 2005 Jul;116(1):160-7. doi: 10.1542/peds.2004-2312. Pediatrics. 2005. PMID: 15995047
Immunogenicity of a 7-valent pneumococcal conjugate vaccine (PCV7) and impact on carriage in Venezuelan children at risk of invasive pneumococcal diseases.
Rivera-Olivero IA, Del Nogal B, Fuentes M, Cortez R, Bogaert D, Hermans PW, Waard JH. Rivera-Olivero IA, et al. Vaccine. 2014 Jun 30;32(31):4006-11. doi: 10.1016/j.vaccine.2014.04.027. Epub 2014 May 14. Vaccine. 2014. PMID: 24837505
186 results
Jump to page
Feedback